MyBlueDots

Validic Advances Personalized Patient Care by Integrating Wearable Data in EHR Workflow

LAS VEGAS–(BUSINESS WIRE)– #applewatch–CES–Validic, a leader in digital health and personalized care technology, today announced the integration of physical activity data from wearables and smartwatches into electronic health record (EHR) clinical workflows. This multi-device solution, available in Epic and Oracle Health EHR systems, adds daily insights from more than 350 wearable device models from leading consumer brands, including Apple, Fitbit, Garmin, Google, Oura, Samsung, and Withings to the patie
Read More

CORRECTING and REPLACING PharmaEssentia Announces Positive Topline Phase 3 Data from SURPASS-ET Study Evaluating Ropeginterferon Alfa-2b-njft (P1101) for Essential Thrombocythemia

BURLINGTON, Mass.–(BUSINESS WIRE)–Please replace the release dated January 6, 2025, with the following corrected version due to multiple revisions. The updated release reads: PHARMAESSENTIA ANNOUNCES POSITIVE TOPLINE PHASE 3 DATA FROM SURPASS-ET STUDY EVALUATING ROPEGINTERFERON ALFA-2B-NJFT (P1101) FOR ESSENTIAL THROMBOCYTHEMIA SURPASS-ET trial achieved its primary endpoint, demonstrating a durable response in 42.9% of participants in the P1101 group versus 6.0% in the comparator group (p=0.0
Read More

Dr. Timothy A. Schaub Joins Luskin Orthopaedic Institute for Children as Head of Hand and Microsurgery Center

LOS ANGELES–(BUSINESS WIRE)– #HolidayGiving–The Luskin Orthopaedic Institute for Children (LuskinOIC) proudly announces the appointment of Dr. Timothy A. Schaub, M.D., F.A.C.S., MBA as the Head of the Hand and Microsurgery Center. With a distinguished career spanning decades and a reputation for innovative approaches in pediatric hand and microsurgical care, Dr. Schaub brings unparalleled expertise to LuskinOIC’s mission of providing world-class, compassionate care to children. Dr. Schaub joined LuskinOIC in
Read More

Grove Secures $4.9 Million to Transform Clinical Trials with Agentic AI

SAN FRANCISCO–(BUSINESS WIRE)–Grove AI, a next-generation clinical trial management and intelligence company, today announced a $4.9 million seed fundraise led by A*, with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels. This investment will allow Grove to continue scaling its team and product to redefine clinical trials from siloed operations into participant-centered ecosystems driven by real-time data. Despite their vital role in adv
Read More

Cell Therapy Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 953 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell Therapy Collaboration and Licensing Deals 2016-2024” report has been added to ResearchAndMarkets.com’s offering. Cell Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the cell therapy deals entered into by the world’s leading biopharma companies. Understand deal trends since 2016 Browse cell therapy collaboration and licensing deals Benchmark analysis – identify market value of transactions Financials
Read More

HealthTech Business Organisation Study: How to Organize Digital Health Businesses, Especially at Large Pharma and MedTech companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “How to Organize a HealthTech Business?” report has been added to ResearchAndMarkets.com’s offering. This report sheds light on how to organize digital health businesses, especially at large Pharma and MedTech companies. By looking at how other companies have been managing their HealthTech businesses over the last 15 years, 11 different HealthTech organizational archetypes are being detailed out in the report, including their objectives, responsibilities, team sizes
Read More
Top